1570 related articles for article (PubMed ID: 30834237)
1. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
Tagliaferri TL; Jansen M; Horz HP
Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
[TBL] [Abstract][Full Text] [Related]
2. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Luong T; Salabarria AC; Roach DR
Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
[TBL] [Abstract][Full Text] [Related]
3. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary Rationale for Phages as Complements of Antibiotics.
Torres-Barceló C; Hochberg ME
Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
[TBL] [Abstract][Full Text] [Related]
5. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
[TBL] [Abstract][Full Text] [Related]
6. A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans.
El Haddad L; Harb CP; Gebara MA; Stibich MA; Chemaly RF
Clin Infect Dis; 2019 Jun; 69(1):167-178. PubMed ID: 30395179
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Novel
Mulani MS; Kumkar SN; Pardesi KR
Microbiol Spectr; 2022 Dec; 10(6):e0199422. PubMed ID: 36374021
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal Synergism between Phage YC#06 and Antibiotics: a Combination Strategy to Target Multidrug-Resistant Acinetobacter baumannii
Luo J; Xie L; Liu M; Li Q; Wang P; Luo C
Microbiol Spectr; 2022 Aug; 10(4):e0009622. PubMed ID: 35736241
[TBL] [Abstract][Full Text] [Related]
9. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
[TBL] [Abstract][Full Text] [Related]
10. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
Viertel TM; Ritter K; Horz HP
J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
[TBL] [Abstract][Full Text] [Related]
11. A simple solid media assay for detection of synergy between bacteriophages and antibiotics.
Khong E; Oh JJ; Jimenez JM; Liu R; Dunham S; Monsibais A; Rhoads A; Ghatbale P; Garcia A; Cobián Güemes AG; Blanc AN; Chiu M; Kuo P; Proost M; Kline A; Aslam S; Schooley RT; Whiteson K; Fraley SI; Pride DT
Microbiol Spectr; 2024 May; 12(5):e0322123. PubMed ID: 38526142
[TBL] [Abstract][Full Text] [Related]
12. [System analysis of the ecological distribution of bacteriophages in hospital wastewater].
Lu JY; Pan HW; Sun EH; Li W; Wang HX; Zhao XL; Wang HC
Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Feb; 58(2):241-247. PubMed ID: 38387957
[TBL] [Abstract][Full Text] [Related]
13. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.
Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ
Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889
[TBL] [Abstract][Full Text] [Related]
14. Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections
Kebriaei R; Lev KL; Shah RM; Stamper KC; Holger DJ; Morrisette T; Kunz Coyne AJ; Lehman SM; Rybak MJ
Microbiol Spectr; 2022 Apr; 10(2):e0041122. PubMed ID: 35348366
[TBL] [Abstract][Full Text] [Related]
15. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
Royer S; Morais AP; da Fonseca Batistão DW
Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
[TBL] [Abstract][Full Text] [Related]
16. A combination therapy of Phages and Antibiotics: Two is better than one.
Li X; He Y; Wang Z; Wei J; Hu T; Si J; Tao G; Zhang L; Xie L; Abdalla AE; Wang G; Li Y; Teng T
Int J Biol Sci; 2021; 17(13):3573-3582. PubMed ID: 34512166
[TBL] [Abstract][Full Text] [Related]
17. Phage-based therapy against biofilm producers in gram-negative ESKAPE pathogens.
Ragupathi NKD; Muthuirulandi Sethuvel DP; Gopikrishnan M; Dwarakanathan HT; Murugan D; Biswas I; Bakthavachalam YD; Murugesan M; George Priya Doss C; Monk PN; Karunakaran E; Veeraraghavan B
Microb Pathog; 2023 May; 178():106064. PubMed ID: 36898591
[TBL] [Abstract][Full Text] [Related]
18. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
Kulshrestha M; Tiwari M; Tiwari V
Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
[TBL] [Abstract][Full Text] [Related]
19. Ameliorating the antimicrobial resistance crisis: phage therapy.
Saha D; Mukherjee R
IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
[TBL] [Abstract][Full Text] [Related]
20. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
